Investors & Media

Sanj K. Patel to Introduce Kiniksa Pharmaceuticals at 35th Annual J.P. Morgan Healthcare Conference

December 20, 2016


Hamilton, Bermuda—Kiniksa Pharmaceuticals, Ltd., a privately-held biotechnology company focused on developing and delivering therapeutics to patients with devastating diseases and unmet medical needs, announced that Chairman and Chief Executive Officer, Sanj K. Patel, will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, January 11, 2017, at 8:30 a.m. PST.

“The management team from Synageva BioPharma Corp. has reassembled, creating a new company with a patient-driven mission to develop and commercialize life-altering therapies for devastating diseases” said Patel. “Our team brings world-class leadership across all functional areas necessary to achieve our goal of building a global generational company.”

Kiniksa posts information that may be important to investors on the company’s website at www.kiniksa.com. Kiniksa encourages interested parties to consult this website regularly for important information about the company.

Further information regarding Kiniksa is available at www.kiniksa.com.

“Kiniksa” is a trademark of Kiniksa Pharmaceuticals, Ltd.

Contacts
Kiniksa Pharmaceuticals
Chris Heberlig, 781-430-8540
Chief Financial Officer
cheberlig@kiniksa.com